Neurological Symptoms of FIP

Feline Infectious Peritonitis (FIP) is a complex, often fatal disease caused by mutated feline coronavirus (FCoV). While FIP commonly manifests with abdominal or thoracic effusions, a significant subset of affected cats exhibit neurological signs. Understanding these neurological manifestations is critical for accurate diagnosis, management, and prognosis.

Pathophysiology and Central Nervous System Involvement

FIP-associated neurological symptoms primarily result from vasculitis and granulomatous inflammation within the central nervous system (CNS). The virus invades the CNS through hematogenous spread, crossing the blood-brain barrier, or via cranial nerves. Once inside, it incites an immune-mediated inflammatory response, leading to tissue damage. The inflammatory infiltration predominantly targets the meninges, choroid plexus, and ependymal lining, disrupting normal neurological functions.

Common Neurological Clinical Presentations

Cats with neurological FIP frequently present with a combination of clinical signs that reflect the areas of CNS affected:

Seizures: Often focal or generalized, seizures result from cortical irritation or increased intracranial pressure due to edema or inflammatory masses.

Ataxia: Generalized uncoordinated movements, especially with cerebellar or vestibular involvement, are common.

Mentation Changes: Altered mental state, ranging from lethargy to coma, indicates extensive CNS pathology.

Papilledema: Swelling of the optic disc observed during fundic examination reflects increased intracranial pressure.

Circling and Head Tilt: Behavioral anomalies like circling or head tilting suggest cerebellar or vestibular system involvement.

Nystagmus: Involuntary eye movements point to brainstem or cerebellar lesions.

Focal Neurological Deficits: Hemiparesis, proprioceptive deficits, or cranial nerve dysfunctions may be observed depending on lesion location.

Imaging Features and Diagnostic Indicators

Neuroimaging techniques such as MRI and CT scans are invaluable for detecting CNS lesions in FIP:

MRI Findings: Lesions often appear as hyperintense areas in T2-weighted images, representing inflammatory tissue, edema, or granulomas. Contrast enhancement indicates active inflammation or vascular disruption.

CT Scans: May reveal ventricular dilation, masses, or areas of hypodensity consistent with edema or inflammation.

Clinical imaging, combined with cerebrospinal fluid (CSF) analysis revealing lymphocytic pleocytosis and increased protein content, supports the diagnosis. The detection of FCoV RNA in CSF via PCR further substantiates CNS involvement.

Differential Diagnosis and Challenges

Due to overlapping clinical and imaging features, differentiating FIP from other CNS diseases such as toxoplasmosis, neoplasia, or bacterial meningitis can be complicated. The presence of concurrent systemic signs—like pyogranulomatous granulomas in organs—is suggestive but not definitive.

Prognosis and Management Considerations

Neurological FIP generally carries a grim prognosis, with limited response to current treatments. Supportive care focuses on symptom management, including anticonvulsants for seizures, corticosteroids to reduce inflammation, and supportive therapy to maintain hydration and nutrition. Experimental antiviral agents and immunomodulators are under investigation, but their efficacy remains unproven in many cases.

Unique Aspects of FIP-Induced Neurological Disease

Recent studies indicate that the mutation rate of feline coronavirus correlates with CNS affinity, suggesting a genetic predisposition influencing neurological involvement. Moreover, the variability in clinical signs underscores the need for comprehensive neurological assessment in suspected cases. Emerging biomarkers, such as specific cytokine profiles in CSF, are promising tools for early detection and differential diagnosis, potentially guiding more targeted therapy in the future.

References

1. Pedersen, N. C. (2014). An update on feline coronavirus: Molecular basis of pathogenesis and vaccine development. Veterinary Immunology and Immunopathology, 158(1–2), 55–62.

2. Addie, D. D., & Jarrett, O. (2008). Feline infectious peritonitis virus. The Veterinary Clinics of North America: Small Animal Practice, 38(5), 943–956.

3. Hartmann, K. (2010). Feline infectious peritonitis. The Veterinary Clinics of North America: Small Animal Practice, 40(1), 61–73.

4. Kipar, A., & Meli, M. L. (2014). Feline infectious peritonitis: Still an enigma? Veterinary Pathology, 51(2), 505–526.

5. Pedersen, N. C., & Body, M. (2019). Feline infectious peritonitis: Update and disease pathogenesis. Veterinary Journal, 245, 20–27.